Latest News

FDA approves mavorixafor as first drug for WHIM syndrome | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves mavorixafor as first drug for WHIM syndrome

April 29th 2024

The rare genetic disease causes the body's immune system to not function properly.

FDA accepts sNDA for tapinarof cream, 1% to treat AD in children 2 years and up | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA accepts sNDA for tapinarof cream, 1% to treat AD in children 2 years and up

April 29th 2024

FDA approves diazepam for seizure clusters in patients 2 to 5 years | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves diazepam for seizure clusters in patients 2 to 5 years

April 29th 2024

Image Credit: © Artur - © Artur - stock.adobe.com.
Week in review: FDA approvals, CRL for DEB, and more

April 26th 2024

COVID-19 vaccines safe for children, despite observed myocarditis, seizure risks
COVID-19 vaccines safe for children, despite observed myocarditis, seizure risks

April 26th 2024

Latest Videos
Podcasts

All News

© 2024 MJH Life Sciences

All rights reserved.